🇫🇷
France · FR · FR:67219072
APTIVUS 250 mg, capsule molle
ReimbursedATC J05AE09
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBOEHRINGER INGELHEIM INTERNATIONAL
CountryFR (France)
ATC codeJ05AE09
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009369252431 flacon(s) polyéthylène haute densité (PEHD) de 120 capsule(s) avec fermeture de sécurité enfantEUR 797.09
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67219072",
"date_amm": "2005-10-25",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/05/315",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "capsule molle",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code J05AE09.
- DKAptivusBoehringer Ingelheim Int. GmbH
- FIAptivusBoehringer Ingelheim International GmbH
- PLAptivusBoehringer Ingelheim International GmbH
- ISAptivusBoehringer Ingelheim International GmbH*
- ISAptivusBoehringer Ingelheim International GmbH*
- FIAptivusBoehringer Ingelheim International GmbH
- 🇺🇸AptivusBoehringer Ingelheim Pharmaceuticals, Inc.
- CZAPTIVUSBoehringer Ingelheim International GmbH, Ingelheim am Rhein
Access this data programmatically
Query APTIVUS 250 mg, capsule molle and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.